End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
322,000 KRW | +1.74% | -1.53% | -8.65% |
05-08 | Invion Partners with Hanlim Pharma for Glioblastoma Treatment | MT |
05-01 | Hanmi Pharm Q1 Profit Surges 27.5%, Sales Up 11.8% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.65% | 2.97B | |
+21.98% | 43.92B | |
+22.95% | 23.09B | |
+19.25% | 15.35B | |
+14.03% | 13.61B | |
+46.40% | 12.02B | |
-10.49% | 7B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.6B |
- Stock Market
- Equities
- A128940 Stock
- News Hanmi Pharm. Co., Ltd.
- US FDA Recommends Clinical Trials for Hanmi Pharm's Invetigational Fatty Liver Disease Drug